Results 111 to 120 of about 17,018 (240)
Objective: Demodex blepharitis is a common inflammatory eye condition caused by an overgrowth of Demodex mites on the eyelids, and lash follicles, Zeiss’ glands and Meibomian glands that is often overlooked.
Oktay Alver +2 more
doaj +1 more source
Rheumatology &Autoimmunity, Volume 6, Issue 1, Page 60-62, March 2026.
Lilian Vasaitis +5 more
wiley +1 more source
A rosacea cután és oculáris megjelenési formái [PDF]
L
Baltás, Eszter +3 more
core +1 more source
Ocular Microbiome in Dupilumab‐Induced Ocular Surface Disease
Allergy, Volume 81, Issue 3, Page 917-919, March 2026.
Andrea Leonardi +4 more
wiley +1 more source
Lotilaner ophthalmic solution 0.25% in the treatment of blepharitis: A case report
Demodex blepharitis is a chronic inflammatory ocular condition caused by Demodex mite infestation of the eyelid that can negatively impact quality of life.
Paul Karpecki +14 more
doaj +1 more source
Multiple Eyelid Signs are Suggestive of Demodex Infestation
Lunla Udomwech, Nonthapan Phasuk School of Medicine, Walailak University, Nakhon Si Thammarat, ThailandCorrespondence: Lunla UdomwechSchool of Medicine, Walailak University, 222 Thaiburi, Tha Sala, Nakhon Si Thammarat, 80160, ThailandTel +6675 672 801Fax
Udomwech L, Phasuk N
doaj
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye [PDF]
Cyclosporine A (Cs) has been used as effective topical therapy for inflammatory dry eye disease since more than a decade. However, due to its lipophilic character, Cs is formulated as emulsions or oily solutions for topical application. This experimental
Maria Notara +4 more
core +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 392-396, March 2026.
Edwin Cuperus +7 more
wiley +1 more source
The role of Helicobacter pylori in the development of inflammatory eyelid diseases
Background. Blepharitis is one of the most common eye diseases: it accounts for 23.3 % of the total number of patients with inflammatory eye diseases worldwide. 40.2 % of these patients seek outpatient care.
E. P. Kazantseva +8 more
doaj +1 more source

